Insight

Dec 20, 2024, 13:52

Biosimilars offer innovative treatment options for cancer care – UICC

Union for International Cancer Control (UICC) posted the following on LinkedIn:

“Biosimilars may be the key to expanding treatment options for cancer patients worldwide. But what are they, and how do they work? Discover the science behind these innovative therapies and their potential to reshape cancer care.

Watch this insightful content, produced with the support of Celltrion Inc., as part of the Rewriting Cancer series produced by BBC StoryWorks and presented by the Union for International Cancer Control (UICC).”

BBC StoryWorks biosimilars cancer cancer innovation cancer treatment Celltrion Inc. global oncology innovative therapies OncoDaily Oncology patient care Rewriting Cancer series UICC

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Bispecific Antibody M701 Offers a Novel Treatment Option for Malignant Ascites

Special Coverage